Showing results (651-660 of 4,871) with videos related to

Sort By:
Pageof 488
Urologic Oncology|December 23, 2018
Quantifying downstream impact of inappropriate staging imaging in a cohort of veterans with low- and intermediate-risk incident prostate cancerSiri Drangsholt, Dawn Walter, Shannon Ciprut, et al.
Urologic Oncology|February 11, 2018
Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinomaWalter Henriques da Costa, Isabela Werneck da Cunha, Aline Fusco Fares, et al.
Urologic Oncology|February 11, 2018
The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancerAlessandra Allione, Barbara Pardini, Clara Viberti, et al.
Urologic Oncology|February 13, 2018
Metabolic syndrome is not associated with greater evidences of proliferative inflammatory atrophy and inflammation in patients with suspected prostate cancerGiorgio I Russo, Sebastiano Cimino, Giorgia Giranio, et al.
Urologic Oncology|April 1, 2018
Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancerMarco Moschini, Emilio Arbelaez, Julian Cornelius, et al.
Urologic Oncology|November 28, 2018
Age-related variations in gene expression patterns of renal cell carcinomaLara Feulner, Hamed S Najafabadi, Simon Tanguay, et al.
Urologic Oncology|November 28, 2018
Delivery of chemotherapy for testicular cancer in routine practice: A population-based studySafiya Karim, Xuejiao Wei, Michael J Leveridge, et al.
Urologic Oncology|November 28, 2018
Mutations in renal cell carcinomaChristopher D'Avella, Phillip Abbosh, Sumanta K Pal, et al.
Urologic Oncology|January 19, 2019
Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder CancerSanaa Eissa, Maheera Safwat, Marwa Matboli, et al.
Urologic Oncology|November 2, 2019
Granulocytic myeloid-derived suppressor cells correlate with outcomes undergoing neoadjuvant chemotherapy for bladder cancerGuoliang Yang, Mengyao Liu, Qiang Liu, et al.
Pageof 488